Genomics Market in US 2024-2028

Genomics Market In US 2024-2028


The genomics market in US is forecasted to grow by USD 6966.8 mn during 2023-2028, accelerating at a CAGR of 12.1% during the forecast period. The report on the genomics market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by reduction in cost of genetic sequencing, increasing demand for creating and upgrading genome databases, and growing demand for personalized medicine.

Technavio's genomics market in US is segmented as below:
  • By Application
  • Diagnostics
  • Drug discovery
  • Others
  • By End-user
  • Hospitals and clinics
  • Academic and research institutes
  • Pharmaceutical and biotechnology companies
  • Others
  • By Solution
  • Products
  • Services
  • By Geographical Landscape
  • North America
This study identifies the growing adoption of single cell-based genomics analysis as one of the prime reasons driving the genomics market in US growth during the next few years. Also, advances in sequencing technologies and growing applications of genomics in oncology will lead to sizable demand in the market.

The report on the genomics market in US covers the following areas:
  • Genomics Market in US sizing
  • Genomics Market in US forecast
  • Genomics Market in US industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genomics market in US vendors that include Agilent Technologies Inc., BGI Genomics Co. Ltd., Bio RAD Laboratories Inc., Caris Life Sciences, CENTOGENE NV, Color Health Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Invitae Corp., LetsGetChecked, Myriad Genetics Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc., Perkin Elmer Inc., Personalis Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., and Twist Bioscience Corp.. Also, the genomics market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Country Market Characteristics
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Solution
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US: Year-over-year growth 2023-2028 (%)
Data Table on US: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Genomics Market in US 2018 - 2022
Historic Market Size - Data Table on Genomics Market in US 2018 - 2022 ($ million)
4.2 Application segment analysis 2018 - 2022
Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 End-user segment analysis 2018 - 2022
Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Solution segment analysis 2018 - 2022
Historic Market Size - Solution Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Chart on Application - Market share 2023-2028 (%)
Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
6.3 Diagnostics - Market size and forecast 2023-2028
Chart on Diagnostics - Market size and forecast 2023-2028 ($ million)
Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million)
Chart on Diagnostics - Year-over-year growth 2023-2028 (%)
Data Table on Diagnostics - Year-over-year growth 2023-2028 (%)
6.4 Drug discovery - Market size and forecast 2023-2028
Chart on Drug discovery - Market size and forecast 2023-2028 ($ million)
Data Table on Drug discovery - Market size and forecast 2023-2028 ($ million)
Chart on Drug discovery - Year-over-year growth 2023-2028 (%)
Data Table on Drug discovery - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
7.3 Hospitals and clinics - Market size and forecast 2023-2028
Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
7.4 Academics and research institutes - Market size and forecast 2023-2028
Chart on Academics and research institutes - Market size and forecast 2023-2028 ($ million)
Data Table on Academics and research institutes - Market size and forecast 2023-2028 ($ million)
Chart on Academics and research institutes - Year-over-year growth 2023-2028 (%)
Data Table on Academics and research institutes - Year-over-year growth 2023-2028 (%)
7.5 Pharmaceuticals and biotechnology companies - Market size and forecast 2023-2028
Chart on Pharmaceuticals and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Data Table on Pharmaceuticals and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Chart on Pharmaceuticals and biotechnology companies - Year-over-year growth 2023-2028 (%)
Data Table on Pharmaceuticals and biotechnology companies - Year-over-year growth 2023-2028 (%)
7.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
8 Market Segmentation by Solution
8.1 Market segments
Chart on Solution - Market share 2023-2028 (%)
Data Table on Solution - Market share 2023-2028 (%)
8.2 Comparison by Solution
Chart on Comparison by Solution
Data Table on Comparison by Solution
8.3 Products - Market size and forecast 2023-2028
Chart on Products - Market size and forecast 2023-2028 ($ million)
Data Table on Products - Market size and forecast 2023-2028 ($ million)
Chart on Products - Year-over-year growth 2023-2028 (%)
Data Table on Products - Year-over-year growth 2023-2028 (%)
8.4 Services - Market size and forecast 2023-2028
Chart on Services - Market size and forecast 2023-2028 ($ million)
Data Table on Services - Market size and forecast 2023-2028 ($ million)
Chart on Services - Year-over-year growth 2023-2028 (%)
Data Table on Services - Year-over-year growth 2023-2028 (%)
8.5 Market opportunity by Solution
Market opportunity by Solution ($ million)
Data Table on Market opportunity by Solution ($ million)
9 Customer Landscape
9.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Agilent Technologies Inc.
Agilent Technologies Inc. - Overview
Agilent Technologies Inc. - Business segments
Agilent Technologies Inc. - Key news
Agilent Technologies Inc. - Key offerings
Agilent Technologies Inc. - Segment focus
12.4 BGI Genomics Co. Ltd.
BGI Genomics Co. Ltd. - Overview
BGI Genomics Co. Ltd. - Product / Service
BGI Genomics Co. Ltd. - Key offerings
12.5 Bio Rad Laboratories Inc.
Bio Rad Laboratories Inc. - Overview
Bio Rad Laboratories Inc. - Business segments
Bio Rad Laboratories Inc. - Key news
Bio Rad Laboratories Inc. - Key offerings
Bio Rad Laboratories Inc. - Segment focus
12.6 Color Health Inc.
Color Health Inc. - Overview
Color Health Inc. - Product / Service
Color Health Inc. - Key offerings
12.7 Danaher Corp.
Danaher Corp. - Overview
Danaher Corp. - Business segments
Danaher Corp. - Key news
Danaher Corp. - Key offerings
Danaher Corp. - Segment focus
12.8 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.9 Illumina Inc.
Illumina Inc. - Overview
Illumina Inc. - Business segments
Illumina Inc. - Key news
Illumina Inc. - Key offerings
Illumina Inc. - Segment focus
12.10 LetsGetChecked
LetsGetChecked - Overview
LetsGetChecked - Product / Service
LetsGetChecked - Key offerings
12.11 Myriad Genetics Inc.
Myriad Genetics Inc. - Overview
Myriad Genetics Inc. - Product / Service
Myriad Genetics Inc. - Key news
Myriad Genetics Inc. - Key offerings
12.12 Oxford Nanopore Technologies plc
Oxford Nanopore Technologies plc - Overview
Oxford Nanopore Technologies plc - Product / Service
Oxford Nanopore Technologies plc - Key offerings
12.13 Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc. - Overview
Pacific Biosciences of California Inc. - Product / Service
Pacific Biosciences of California Inc. - Key news
Pacific Biosciences of California Inc. - Key offerings
12.14 Perkin Elmer Inc.
Perkin Elmer Inc. - Overview
Perkin Elmer Inc. - Business segments
Perkin Elmer Inc. - Key news
Perkin Elmer Inc. - Key offerings
Perkin Elmer Inc. - Segment focus
12.15 QIAGEN N.V.
QIAGEN N.V. - Overview
QIAGEN N.V. - Product / Service
QIAGEN N.V. - Key news
QIAGEN N.V. - Key offerings
12.16 Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
12.17 Twist Bioscience Corp.
Twist Bioscience Corp. - Overview
Twist Bioscience Corp. - Product / Service
Twist Bioscience Corp. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Country Market Characteristics
Exhibits4: Executive Summary - Chart on Market Segmentation by Application
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Solution
Exhibits7: Executive Summary - Chart on Company Market Positioning
Exhibits8: Parent Market
Exhibits9: Data Table on - Parent Market
Exhibits10: Market characteristics analysis
Exhibits11: Value Chain Analysis
Exhibits12: Offerings of companies included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on US: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on US: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on Genomics Market in US 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Solution Segment 2018 - 2022 ($ million)
Exhibits22: Five forces analysis - Comparison between 2023 and 2028
Exhibits23: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits24: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits25: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits26: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits27: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits28: Chart on Market condition - Five forces 2023 and 2028
Exhibits29: Chart on Application - Market share 2023-2028 (%)
Exhibits30: Data Table on Application - Market share 2023-2028 (%)
Exhibits31: Chart on Comparison by Application
Exhibits32: Data Table on Comparison by Application
Exhibits33: Chart on Diagnostics - Market size and forecast 2023-2028 ($ million)
Exhibits34: Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million)
Exhibits35: Chart on Diagnostics - Year-over-year growth 2023-2028 (%)
Exhibits36: Data Table on Diagnostics - Year-over-year growth 2023-2028 (%)
Exhibits37: Chart on Drug discovery - Market size and forecast 2023-2028 ($ million)
Exhibits38: Data Table on Drug discovery - Market size and forecast 2023-2028 ($ million)
Exhibits39: Chart on Drug discovery - Year-over-year growth 2023-2028 (%)
Exhibits40: Data Table on Drug discovery - Year-over-year growth 2023-2028 (%)
Exhibits41: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits42: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits43: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits44: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits45: Market opportunity by Application ($ million)
Exhibits46: Data Table on Market opportunity by Application ($ million)
Exhibits47: Chart on End-user - Market share 2023-2028 (%)
Exhibits48: Data Table on End-user - Market share 2023-2028 (%)
Exhibits49: Chart on Comparison by End-user
Exhibits50: Data Table on Comparison by End-user
Exhibits51: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits52: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits53: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits54: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits55: Chart on Academics and research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits56: Data Table on Academics and research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits57: Chart on Academics and research institutes - Year-over-year growth 2023-2028 (%)
Exhibits58: Data Table on Academics and research institutes - Year-over-year growth 2023-2028 (%)
Exhibits59: Chart on Pharmaceuticals and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibits60: Data Table on Pharmaceuticals and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibits61: Chart on Pharmaceuticals and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits62: Data Table on Pharmaceuticals and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits63: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits64: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits65: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits67: Market opportunity by End-user ($ million)
Exhibits68: Data Table on Market opportunity by End-user ($ million)
Exhibits69: Chart on Solution - Market share 2023-2028 (%)
Exhibits70: Data Table on Solution - Market share 2023-2028 (%)
Exhibits71: Chart on Comparison by Solution
Exhibits72: Data Table on Comparison by Solution
Exhibits73: Chart on Products - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Products - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Products - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Products - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Services - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Services - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Services - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Services - Year-over-year growth 2023-2028 (%)
Exhibits81: Market opportunity by Solution ($ million)
Exhibits82: Data Table on Market opportunity by Solution ($ million)
Exhibits83: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits84: Impact of drivers and challenges in 2023 and 2028
Exhibits85: Overview on criticality of inputs and factors of differentiation
Exhibits86: Overview on factors of disruption
Exhibits87: Impact of key risks on business
Exhibits88: Companies covered
Exhibits89: Matrix on companies position and classification
Exhibits90: Agilent Technologies Inc. - Overview
Exhibits91: Agilent Technologies Inc. - Business segments
Exhibits92: Agilent Technologies Inc. - Key news
Exhibits93: Agilent Technologies Inc. - Key offerings
Exhibits94: Agilent Technologies Inc. - Segment focus
Exhibits95: BGI Genomics Co. Ltd. - Overview
Exhibits96: BGI Genomics Co. Ltd. - Product / Service
Exhibits97: BGI Genomics Co. Ltd. - Key offerings
Exhibits98: Bio Rad Laboratories Inc. - Overview
Exhibits99: Bio Rad Laboratories Inc. - Business segments
Exhibits100: Bio Rad Laboratories Inc. - Key news
Exhibits101: Bio Rad Laboratories Inc. - Key offerings
Exhibits102: Bio Rad Laboratories Inc. - Segment focus
Exhibits103: Color Health Inc. - Overview
Exhibits104: Color Health Inc. - Product / Service
Exhibits105: Color Health Inc. - Key offerings
Exhibits106: Danaher Corp. - Overview
Exhibits107: Danaher Corp. - Business segments
Exhibits108: Danaher Corp. - Key news
Exhibits109: Danaher Corp. - Key offerings
Exhibits110: Danaher Corp. - Segment focus
Exhibits111: F. Hoffmann La Roche Ltd. - Overview
Exhibits112: F. Hoffmann La Roche Ltd. - Business segments
Exhibits113: F. Hoffmann La Roche Ltd. - Key news
Exhibits114: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits115: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits116: Illumina Inc. - Overview
Exhibits117: Illumina Inc. - Business segments
Exhibits118: Illumina Inc. - Key news
Exhibits119: Illumina Inc. - Key offerings
Exhibits120: Illumina Inc. - Segment focus
Exhibits121: LetsGetChecked - Overview
Exhibits122: LetsGetChecked - Product / Service
Exhibits123: LetsGetChecked - Key offerings
Exhibits124: Myriad Genetics Inc. - Overview
Exhibits125: Myriad Genetics Inc. - Product / Service
Exhibits126: Myriad Genetics Inc. - Key news
Exhibits127: Myriad Genetics Inc. - Key offerings
Exhibits128: Oxford Nanopore Technologies plc - Overview
Exhibits129: Oxford Nanopore Technologies plc - Product / Service
Exhibits130: Oxford Nanopore Technologies plc - Key offerings
Exhibits131: Pacific Biosciences of California Inc. - Overview
Exhibits132: Pacific Biosciences of California Inc. - Product / Service
Exhibits133: Pacific Biosciences of California Inc. - Key news
Exhibits134: Pacific Biosciences of California Inc. - Key offerings
Exhibits135: Perkin Elmer Inc. - Overview
Exhibits136: Perkin Elmer Inc. - Business segments
Exhibits137: Perkin Elmer Inc. - Key news
Exhibits138: Perkin Elmer Inc. - Key offerings
Exhibits139: Perkin Elmer Inc. - Segment focus
Exhibits140: QIAGEN N.V. - Overview
Exhibits141: QIAGEN N.V. - Product / Service
Exhibits142: QIAGEN N.V. - Key news
Exhibits143: QIAGEN N.V. - Key offerings
Exhibits144: Thermo Fisher Scientific Inc. - Overview
Exhibits145: Thermo Fisher Scientific Inc. - Business segments
Exhibits146: Thermo Fisher Scientific Inc. - Key news
Exhibits147: Thermo Fisher Scientific Inc. - Key offerings
Exhibits148: Thermo Fisher Scientific Inc. - Segment focus
Exhibits149: Twist Bioscience Corp. - Overview
Exhibits150: Twist Bioscience Corp. - Product / Service
Exhibits151: Twist Bioscience Corp. - Key offerings
Exhibits152: Inclusions checklist
Exhibits153: Exclusions checklist
Exhibits154: Currency conversion rates for US$
Exhibits155: Research methodology
Exhibits156: Information sources
Exhibits157: Data validation
Exhibits158: Validation techniques employed for market sizing
Exhibits159: Data synthesis
Exhibits160: 360 degree market analysis
Exhibits161: List of abbreviations

Loading...

In this report,

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings